Voyager Therapeutics Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
5.62
0.09
(1.63%)
Volume:
316,828
52 week range:
4.99 - 10.66
Market Cap:
306.996M
Company Description:
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease.